Fast Five Quiz: Immunologic and Inflammatory Pathways in Severe Asthma

Zab Mosenifar, MD


March 18, 2020

There is a significant need for more precise biomarkers that identify specific disease pathways and can therefore aid in early diagnosis, risk prediction, prognostication, and informed treatment decisions. Biomarkers should help characterize the severity of disease. In general, biomarkers would have a significant impact on every step of severe asthma management.

Learn more on the need for biomarkers.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.